EG18934A - Novel resolution process for racemic spiro hydantoins - Google Patents

Novel resolution process for racemic spiro hydantoins

Info

Publication number
EG18934A
EG18934A EG35689A EG35689A EG18934A EG 18934 A EG18934 A EG 18934A EG 35689 A EG35689 A EG 35689A EG 35689 A EG35689 A EG 35689A EG 18934 A EG18934 A EG 18934A
Authority
EG
Egypt
Prior art keywords
spiro
ureido
compound
racemic
novel
Prior art date
Application number
EG35689A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG18934A publication Critical patent/EG18934A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/06—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
EG35689A 1988-07-27 1989-07-26 Novel resolution process for racemic spiro hydantoins EG18934A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/224,966 US4952694A (en) 1988-07-27 1988-07-27 Novel resolution process for racemic spiro-hydantoins

Publications (1)

Publication Number Publication Date
EG18934A true EG18934A (en) 1994-03-30

Family

ID=22842974

Family Applications (1)

Application Number Title Priority Date Filing Date
EG35689A EG18934A (en) 1988-07-27 1989-07-26 Novel resolution process for racemic spiro hydantoins

Country Status (24)

Country Link
US (1) US4952694A (es)
EP (1) EP0352959B1 (es)
JP (1) JPH0625152B2 (es)
KR (1) KR910002839B1 (es)
CN (1) CN1023645C (es)
AT (1) ATE93859T1 (es)
DD (1) DD284020A5 (es)
DE (1) DE68908812T2 (es)
DK (1) DK169033B1 (es)
EG (1) EG18934A (es)
ES (1) ES2058537T3 (es)
FI (1) FI893576A (es)
HU (1) HU204527B (es)
IE (1) IE892420L (es)
IL (1) IL91055A0 (es)
MX (1) MX173143B (es)
MY (1) MY104136A (es)
NO (1) NO168773C (es)
NZ (1) NZ230091A (es)
PL (1) PL161181B1 (es)
PT (1) PT91273A (es)
RU (1) RU1777599C (es)
YU (1) YU47209B (es)
ZA (1) ZA895680B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5151544A (en) * 1990-05-25 1992-09-29 Alcon Laboratories, Inc. Intermediates in the preparation of chiral spirofluorenehydantoins
US5206367A (en) * 1992-02-18 1993-04-27 Pfizer Inc. Preparation of optically active spiro-hydantoins
US5811605A (en) * 1997-02-19 1998-09-22 Ppg Industries, Inc. Preparation of 1,2,3,3-tetrachloropropene
WO2009011261A1 (ja) 2007-07-19 2009-01-22 Tokuyama Corporation ヒダントイン環を有する化合物及びその製造方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
DE3367103D1 (en) * 1982-11-10 1986-11-27 Pfizer Sorbinil by optical resolution with aminopinane derivatives
ATE37371T1 (de) * 1984-08-20 1988-10-15 Pfizer Verfahren zur herstellung asymmetrischer hydantoine.
WO1986002647A1 (en) * 1984-10-30 1986-05-09 Pfizer Inc. Spiro-heteroazolones for treatment of diabetes complications

Also Published As

Publication number Publication date
JPH0625152B2 (ja) 1994-04-06
DK367889A (da) 1990-01-29
NO168773B (no) 1991-12-23
NO893053D0 (no) 1989-07-26
ATE93859T1 (de) 1993-09-15
YU47209B (sh) 1995-01-31
US4952694A (en) 1990-08-28
ZA895680B (en) 1991-03-27
PT91273A (pt) 1990-02-08
FI893576A0 (fi) 1989-07-26
NO168773C (no) 1992-04-01
FI893576A (fi) 1990-01-28
MY104136A (en) 1994-02-28
KR910002862A (ko) 1991-02-26
AU3898889A (en) 1990-02-01
JPH0288576A (ja) 1990-03-28
PL161181B1 (pl) 1993-05-31
DE68908812T2 (de) 1993-12-09
KR910002839B1 (ko) 1991-05-06
MX173143B (es) 1994-02-02
EP0352959A1 (en) 1990-01-31
CN1023645C (zh) 1994-02-02
AU603301B2 (en) 1990-11-08
YU149189A (en) 1991-02-28
EP0352959B1 (en) 1993-09-01
HU204527B (en) 1992-01-28
NO893053L (no) 1990-01-29
NZ230091A (en) 1991-01-29
ES2058537T3 (es) 1994-11-01
HUT56369A (en) 1991-08-28
CN1040199A (zh) 1990-03-07
IL91055A0 (en) 1990-02-09
DE68908812D1 (de) 1993-10-07
DK169033B1 (da) 1994-08-01
MX16955A (es) 1993-06-01
RU1777599C (ru) 1992-11-23
DK367889D0 (da) 1989-07-26
DD284020A5 (de) 1990-10-31
IE892420L (en) 1990-01-27

Similar Documents

Publication Publication Date Title
AU6585696A (en) Process for the preparation of enantiomerically pure imidazolyl compounds
EG18934A (en) Novel resolution process for racemic spiro hydantoins
AU556793B2 (en) Sorbinil and methylsorbinil
PT77848A (en) Process for the racemisation of spiro compounds